Senate President Ben Albritton, a citrus grower from Hardee County, has made what he calls the “rural renaissance” plan a ...

Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity ...

After enacting a “poison pill” defense to protect itself from unwanted potential buyers, Bausch Health has spotted a major ...

(Reuters) -Billionaire Carl Icahn has built an economic interest covering about 34% of Bausch Health's shares, according to a ...

TOKYO (Reuters) - Private equity giant Carlyle is in talks with Japan's Makino Milling Machine as a potential white knight ...

El Pollo Loco Holdings is a potential buyout target, with Sardar Biglari of Biglari Capital offering to acquire it. See why I ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Shares of Keros Therapeutics (NASDAQ:KROS) added ~22% in the premarket on Thursday after the biotech commenced a review process to evaluate different strategic options, including a potential sale of ...

Keros Therapeutics said on Thursday its board had authorized a stockholder rights plan, also known as a "poison pill", in response to rapid accumulations of the company's stock by some investors.

However, they are not a quick fix. "It's important to note that it's not a magic pill," said Winselow Tucker, President and General Manager at Eli Lilly India. "It's also not for lifestyle.

Women who stop taking the contraceptive pill have reported no longer 'fancying' their partner, leading to arguments and even break-ups. Hormone health expert Mike Kocsis at Balance My Hormones has ...

CINCINNATI (WKRC) - A new study found that an already-existing drug could, when taken by humans, turn blood into mosquito poison that kills the bugs within hours. The study, recently published in ...